 |
 |
--------------DF0AA9BC1E0A3810DF131603 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit > On average, patients taking the drug had more than 2 extra hours of ``on`` time daily, > Adler and colleagues report. These patients were also able to reduce the > dose of levodopa they were taking by more than 20%. > Indeed, it has thus been working well with Barbara who takes 100 mg Tasmar twice a day, and has been able to reduce the Sinemet 25/100 taken 7 times a day to 3-4 times a day, extending the time between dose from 2.5 to 4-5 hrs, and has likewise reduced her Permax by about 20%. But we are still awaiting the cure!!! Michel Margosis --------------DF0AA9BC1E0A3810DF131603 Content-Type: text/html; charset=us-ascii Content-Transfer-Encoding: 7bit <HTML> <BLOCKQUOTE TYPE=CITE> <PRE>On average, patients taking the drug had more than 2 extra hours of ``on`` time daily, Adler and colleagues report. These patients were also able to reduce the dose of levodopa they were taking by more than 20%.</PRE> </BLOCKQUOTE> <P>Indeed, it has thus been working well with Barbara who takes 100 mg Tasmar twice a day, and has been able to reduce the Sinemet 25/100 taken 7 times a day to 3-4 times a day, extending the time between dose from 2.5 to 4-5 hrs, and has likewise reduced her Permax by about 20%. <BR>But we are still awaiting the cure!!! <BR>Michel Margosis</HTML> --------------DF0AA9BC1E0A3810DF131603--